RecruitingNCT06680323

Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults

Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults - Novel Health Care Strategies for Melanoma in Children, Adolescents and Young Adults (MELCAYA)


Sponsor

University Hospital Tuebingen

Enrollment

200 participants

Start Date

Jan 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The primary objective of this study is the identification of environmental and genetic factors involved in the risk and progression of melanoma in children, adolescents and young adults (CAYA). The secondary objectives are to generate a model integrating the genetic and environmental factors to estimate the risk of developing melanoma and improve the primary prevention of melanoma through evidence-based interpretation of environmental risk.


Eligibility

Max Age: 30 Years

Inclusion Criteria2

  • confirmed melanoma
  • age until 30 years old

Exclusion Criteria2

  • no available biological material
  • no signed informed consent

Locations(6)

Leibniz Research Institute for Environmental Medicine

Düsseldorf, Germany

University of Florence

Florence, Italy

Istituto Nazionale del Tumori

Milan, Italy

Medical University of Gdánsk

Gdansk, Poland

Hospital Clínic de Barcelona

Barcelona, Spain

Karolinska Institute

Solna, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06680323


Related Trials